[Corrigendum] MicroRNA‑338 inhibits migration and proliferation by targeting hypoxia‑induced factor 1α in nasopharyngeal carcinoma

Shan,Ying; Li,Xingyu; You,Bo; Shi,Si; Zhang,Qicheng; You,Yiwen

doi:10.3892/or.2022.8358

August-2022 Volume 48 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2022 Volume 48 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] MicroRNA‑338 inhibits migration and proliferation by targeting hypoxia‑induced factor 1α in nasopharyngeal carcinoma

Authors:
- Ying Shan
- Xingyu Li
- Bo You
- Si Shi
- Qicheng Zhang
- Yiwen You
View Affiliations / Copyright

Affiliations: Department of Ear, Nose and Throat, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of Pathology, Medical School of Nantong University, Nantong, Jiangsu 226001, P.R. China

Copyright: © Shan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 146
|
Published online on: June 27, 2022

https://doi.org/10.3892/or.2022.8358
Expand metrics +

Article

Oncol Rep 34: [Related article:] 1943-1952, 2015; DOI: 10.3892/or.2015.4195

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that, for the cell migration assay data shown in Fig. 4B, the data panels representing the ‘miR-NC inhibitor’ and ‘hypoxia’ experiments appeared to contain overlapping sections, such that they may have been derived from the same original source.

Figure 4.

miR-338-3p regulates the metastasis potential of human NPC cell lines in vitro. (A) Cells transfected with miR-338-3p mimics showed a slower wound closure rate than the cells transfected with the non-specific control or miR-338-3p inhibitor under hypoxic conditions. (B) Transwell analysis confirmed the results above that the overexpression of miR-338-3p significantly reduced the metastasis capacity of the CNE2 cells under hypoxic conditions. Data are presented as mean number of migrated cells per HPF (five random fields were analyzed), compared with the control. *P<0.05. (C) Western blot analysis of E-cadherin, and vimentin expression in parental cells, miR-338-3p and miRNA control transfected cells after 24 h under hypoxic conditions compared with cells cultured under normal conditions. A representative blot from three independent experiments is shown. β-actin was used as control.

The authors have re-examined their original data, and realize that Fig. 4B was assembled incorrectly. A corrected version of Fig. 4, showing in Fig. 4B the data from one of the repeated cell migration assay experiments, is shown on the next page. The authors confirm that these data continue to support the main conclusions presented in their paper, and are grateful to the Editor of Oncology Reports for allowing them this opportunity to publish this Corrigendum. They also apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] MicroRNA‑338 inhibits migration and proliferation by targeting hypoxia‑induced factor 1α in nasopharyngeal carcinoma

This article is mentioned in:

Article

Figure 4.

Related Articles